Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization - Concepedia

Concepedia

Publication | Open Access

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization

DOI Full Paper Access

27

Citations

30

References

2023

Year

Kacy S. Yount, Jesse M. Hall, Kyle Caution, Mohamed M. Shamseldin, Myra Guo, Keirsten Marion, Audra R. Fullen, Yimin Huang, Jennifer A. Maynard, Sally A. Quataert,

Frontiers in Immunology

Abstract

These results suggest that TH17 polarized TRM generated by aPV/BcfA may reduce nasal colonization thereby preventing pertussis transmission and subsequent resurgence.

References

	Year	Citations

Page 1